back to archive

SCHIZOPHRENIA
Professional Journal of the American Schizophrenia Foundation
Volume 3 First Quarter 1971

Controlled Fasting Treatment of Schizophrenia in the U.S.S.R. 2
A Cott, MD

Psychogenesis versus Biogenesis: The Issues and the Evidence 11
B Rimland MD, PhD

Letters to the Editor 37

A Vitamin B3 Dependent Family 41
A Hoffer, MD, PhD

Neuropharmacology and Experimental Psychiatry:the Evolution of a Project–A Progress Report 47
AS Marrazzi, MD

The Use of Mega Vitamin therapy in Regulating SevereBehavior Disorders, Drug Abuses and Frank Psychoses 67
G von Hilsheimer, BD; SD Klotz, MD, FACA, FAAA, FASI; G McFall, DO; H Lerner, MD, A Van West, PhD; D Quirk

Book Reviews 74

Award offered 80

 

SCHIZOPHRENIA
Professional Journal of the American Schizophrenia Foundation
Volume 3 Second Quarter 1971

A Symposium on Modern Chemotherapy of Brain Disorders:
Editor's introduction 84
A Hoffer, MD, PhD, FAPA

Chairman's Remarks 85
JR MAclean, MD; H OSMOND, MD

New Treatment Systems for Schizophrenia 87
LR Mosher, MD

An integrated Community System for the Effective Treatment of Schizophrenia 94
DR Hawkins, MD

Orthomolecular Approach to the Treatment of Learning Disabilities 95
A Cott, MD, FAPA

Some Aspects of Our Research Studies on Schizophrenia 106
JA Yaryura-Tobias, MD

Vitamin B3 Dependent Child 107
A. Hoffer, MD, PhD, FAPA

A First Evaluation 114
MW Williams, MD

Current Status of Chemotherapy of Schizophrenia 116
T A Ban, MD

Orthomolecular Psychiatry 129
L Pauling, PhD

Book Reviews 134

Prevention and Treatment of Alcohol-withdrawal Phenomena 136
RV Edwards, MD, FAPA

The Development of My illness 140
An Anonymous Psychologist

 

SCHIZOPHRENIA
Professional Journal of the American Schizophrenia Foundation
Volume 3    Third and Fourth Quarter 1971

Announcing a Change in Name from Schizophrenia to Orthomolecular Psychiatry Inside Front Cover
A. Hoffer, MD, PhD, FAPA

Organic Brain Disorders in the Aetiology of Schizophrenia 150
C Bagley, PhD

The Case of Bartleby 157
H Osmond, MRCP, DPM

The Rewards of Research-A New Clarification of Schizophrenia by the Term "Metabolic Dysperception'' 168
TR Robie, MD, FAPA

Levodopa-Nicotinic Acid interaction in Psychiatric Patients 177
JA Yaryura-Torbias, MD; B Diamond, MS

The Challenging Frontier-Part II: Current Research in the Field of Severe Childhood Mental Illness 181
DJ Beavers, PhD

The Schizophrenic at the Luncheon Table: A Study in Environment Selection 197
FE Cheek, PhD; CM Holstein MS; RM Weisman, MA; RD Smith, BS

Severity in the Functional Psychoses 213
EL Linn, PhD

Imprisonment without Trial 222
Judge TR Blaine ( Retired )